Adenovirus Burden in Allogeneic Hematopoietic Stem Cell Transplantation: Monitoring Versus Symptoms‐Based Testing—A Cost‐Effectiveness Analysis
In conclusion, although AdVi was common, routine monitoring did not improve outcomes and was financially burdensome, suggesting that a machine learning-driven risk-based testing strategy enhances cost-effectiveness while ensuring timely AdV detection and intervention.
Authors
- Estela Giménez (ORCID: https://orcid.org/0000-0003-1774-9790)
- José Luís Piñana (ORCID: https://orcid.org/0000-0001-8533-2562)
- David Navarro (ORCID: https://orcid.org/0000-0003-3010-4110)
- Juan Carlos Hernández‐Boluda (ORCID: https://orcid.org/0000-0002-4289-3113)
- Carlos Solano (ORCID: https://orcid.org/0000-0003-3702-0817)
- Ignacio Torres (ORCID: https://orcid.org/0000-0002-3604-190X)
- Eliseo Albert (ORCID: https://orcid.org/0000-0002-5037-6095)
- Ariadna Pérez (ORCID: https://orcid.org/0000-0003-3596-2130)
Institutions
- Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- INCLIVA Health Research Institute (ES)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1111/tid.70089
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III
- European Regional Development Fund